ABSTRACT
<p><b>OBJECTIVE</b>To screen the effective components of Shenkangwan that regulate endothelial-mesenchymal transition in endothelial cells for optimizing prescription of Shenkangwan.</p><p><b>METHODS</b>ALK5 was identified as one of the target receptors that regulate endothelial-mesenchymal transition of endothelial cells using molecular docking technique. Nine molecules were screened as the candidate effective components in Shenkangwan, among which calycosin, ononin and stigmasterol were selected for testing. Glomerular epithelial cells were exposed to high glucose and treated with calycosin, ononin, or stigmasterol, and the cellular expressions of α-smooth muscle actin (α-SMA) and vimentin mRNA were detected with real-time fluorescence quantitative PCR. The phosphorylation of SMAD2/3 in the cells was detected using Western blotting.</p><p><b>RESULTS</b>Calycosin, ononin and stigmasterol did not produce significant cytotoxicity in glomerular epithelial cells (P>0.05). The cells exposed to high glucose and calycosin treatment showed significantly decreased mRNA levels of α-SMA and vimentin (P<0.05) and inhibited phosphorylation of SMAD2/3. Ononin and stigmasterol did not produce such effects in the cells.</p><p><b>CONCLUSION</b>In endothelial cells with high glucose-induced injury, calycosin can inhibit the up-regulation of α-SMA and vimentin and inhibit phosphorylation of SMAD2/3 to regulate endothelial-mesenchymal transition and improve diabetic nephropathy.</p>
ABSTRACT
<p><b>OBJECTIVE</b>To investigate the association of V89L polymorphism of the SRD5A2 gene with the prognostic factors of prostate cancer (PCa).</p><p><b>METHODS</b>We identified the V89L polymorphic sites of the SRD5A2 gene after Rsa-1 restriction enzyme digestion, observed the distribution of V89L (VV, VL and LL) polymorphism in 112 PCa and 89 benign prostate hyperplasia (BPH) patients, and determined the association of V89L polymorphism with the age, free PSA (fPSA), total PSA (tPSA), fPSA/tPSA ratio, tumor stage and Gleason score of the PCa patients.</p><p><b>RESULTS</b>No statistically significant differences were found in the V89L polymorphism-induced genetic risk frequencies between the PCa and BPH groups (chi2 = 3. 606, df = 2, P = 0. 165), nor any significant correlation between the genotypes of VV and VL + LL and the differences in the fPSA, tPSA, fPSA/tPSA ratio, tumor stage, Gleason score and age of the PCa patients. VV and VL + LL showed no obvious association with the prognostic factors of PCa.</p><p><b>CONCLUSION</b>V89L polymorphism is not related with the prognosis of PCa, but may be indirectly associated with its risk.</p>
Subject(s)
Aged , Aged, 80 and over , Humans , Male , Middle Aged , 3-Oxo-5-alpha-Steroid 4-Dehydrogenase , Genetics , Genotype , Membrane Proteins , Genetics , Neoplasm Staging , Polymorphism, Genetic , Prognosis , Prostatic Neoplasms , Diagnosis , Genetics , PathologyABSTRACT
<p><b>AIM</b>To establish the fingerprint of Corydalis saxicola Bunting injection.</p><p><b>METHODS</b>It was performed by HPLC Kromasil column was used with acetonitrile and H2O as mobile phase. The flow rate was 0.5 mL x min(-1). The detection wavelength was 254 nm. The mass spectrometry detection was performed on a trap equipped with an ESI interface and operated in positive-ionization mode.</p><p><b>RESULTS</b>Eleven components of Corydalis saxicola Bunting were identified by LC-MS and 7 of them were quantified.</p><p><b>CONCLUSION</b>The fingerprint chromatogram could represent the characteristics of Corydalis saxicola Bunting injection. Evaluation of resemblances and results of precision were satisfactory. This method could be used as quality and quantity control.</p>